Texas Biotech, SmithKline deal

The companies will co-develop and market Novastan ( argatroban), TXB's direct inhibitor of thrombin, as anticoagulant therapy in patients

Read the full 194 word article

How to gain access

Continue reading with a
two-week free trial.